MedPath

Impact of an E-learning Tool on Patient Satisfaction, Knowledge and Medication Adherence in Solid Organ Transplantation: A Randomized Controlled Trial

Not Applicable
Completed
Conditions
Solid Organ Transplantation
Interventions
Other: Transplant Medication Information Teaching Tool
Registration Number
NCT01826721
Lead Sponsor
Jennifer Harrison
Brief Summary

Solid organ transplant recipients (SOTR) must follow complex medication regimens and require a substantial amount of education for effective self-management. The current standard of care for post-transplant medication teaching is a Self Medication education program conducted in hospital by the pharmacist. The Transplant Medication Information Teaching Tool (TMITT) is a web-based e-learning tool for SOTR developed at the Toronto General Hospital. The ability to control the content, sequence, pace and timing of education in order to achieve personal learning objectives, as well as the opportunity for ongoing review and reinforcement of information, may be an attractive, convenient and effective teaching modality.

SOTR will be randomly assigned to receive the standard of care or the standard of care plus the TMITT intervention. Primary objectives are to compare patient satisfaction and medication knowledge between the two groups at baseline and 3 months using modified versions of previously published questionnaires. Medication adherence as measured by a multidimensional approach including both subjective and objective components, will also be compared at 3 months. Our hypothesis is that an education strategy that includes both the standard pharmacist teaching followed by a tailored online e-learning intervention post-discharge will lead to improved patient satisfaction, knowledge and medication adherence.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
246
Inclusion Criteria
  • all patients undergoing solid organ transplantation at Toronto General Hospital during the study period
Exclusion Criteria
  • non-English speaking/reading
  • no internet access at home
  • planned discharge to a rehab facility without internet access
  • not on a calcineurin inhibitor (CNI) or sirolimus
  • attending the Self Medication class on the same day as hospital discharge
  • cognitive impairment that precludes participation in Self Medication program (as per the assessment of the transplant pharmacist)
  • incapable of providing informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TMITTTransplant Medication Information Teaching ToolPatients in this arm receive the standard of care plus the TMITT educational intervention.
Primary Outcome Measures
NameTimeMethod
Change in Medication Knowledge Score from baseline to 3 monthsBaseline and 3 months

Medication Knowledge Score consists of 2 parts - recall of medication regimen and multiple choice knowledge questionnaire.

Secondary Outcome Measures
NameTimeMethod
Patient SatisfactionBaseline and 3 months

Patient satisfaction with medication information received.

Medication Adherence3 months

Adherence to the immunosuppressant medication regimen is evaluated using the Multidimensional Adherence Classification System. This consists of patient self-report and measurement of standard deviation of immunosuppressant blood levels.

Trial Locations

Locations (1)

Toronto General Hospital

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath